Tackling the Serious Global Challenges in Infectious Disease

Appili was created to deliver innovative drug development programs for unmet patient needs across a broad spectrum of infectious diseases

Appili leadership is experienced in drug development, infectious disease, business development, and commercialization.

The Appili team fuels innovation by balancing the company’s pipeline with near-to-market opportunities with transformational programs designed to tackle the most serious threats.

Advancing infectious disease drug development programs to provide solutions to patients, doctors, and society.

Appili Therapeutics: Innovation in
Anti-infectives from Bench to Bedside


Appili Celebrates a Notable 2019 and Looks Ahead to Significant Milestones in 2020
Appili Therapeutics Enters Commercial Agreement With Saptalis Pharmaceuticals for Anticipated Launch of ATI-1501 Antibiotic Candidate in the U.S.
Appili Therapeutics Names Dr. Armand Balboni as Chief Executive Officer